Thomas G, Rael L, Shimonkevitz R, Melamed I, Bar-Or D. Autoantibody reaction to myelin basic protein by plasma parvovirus B19 IgG in MS patients. Protein and peptide letters. 2006; 13:109-111.

Rael LT, Ayala-Fierro F, Bar-Or R, Carter DE, Barber DS. Interaction of arsine with hemoglobin in arsine-induced hemolysis. Toxicol Sci. 2006; 90:142-148.

Pearl A, Caspi R, Bar-Or D. Artificial neural network versus subjective scoring in predicting mortality in trauma patientsStudies in health technology and informatics. 2006; 124:1019-1024.

Bar-Or D, Thomas GW, Bar-Or R, Rael LT, Scarborough K, Rao N, Shimonkevitz R. Commercial human albumin preparations for clinical use are immunosuppressive in vitro. Critical care medicine. 2006; 34:1707-1712.

Bar-Or D, Rael LT, Bar-Or R, Thomas GW, Slone DS, Melamed I, Craun ML. Severe systemic immune response syndrome, low plasma paraoxonase activity, and a new albumin species in a traumatized patient with Gaucher’s disease. Clinica chimica acta; international journal of clinical chemistry. 2006; 374:135-139.

Bar-Or D, Rael LT, Bar-Or R, Slone DS, Craun ML. The formation and rapid clearance of a truncated albumin species in a critically ill patient. Clinica chimica acta; international journal of clinical chemistry. 2006; 365:346-349.

Bar-Or D, McDonald MC, Thiemermann C. Reduction of infarct size in a rat model of regional myocardial ischemia and reperfusion by the synthetic peptide DAHK. Critical care medicine. 2006; 34:1955-1959.